The future of the Rare Tumor Initiative is promising, with continued advancements expected in the areas of genomics, immunotherapy, and precision medicine. As the initiative expands, it aims to deepen its collaboration with international partners, harnessing global expertise to tackle rare tumors on a larger scale. By integrating emerging technologies and data analytics, the initiative seeks to revolutionize the landscape of rare cancer research and care, ultimately improving outcomes for patients worldwide.
